These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19131791)

  • 1. Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia.
    Breakey VR; Abdelhaleem M; Weitzman S; Abla O
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):956-8. PubMed ID: 19131791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis associated with precursor B acute lymphoblastic leukemia.
    Kelly C; Salvi S; McClain K; Hayani A
    Pediatr Blood Cancer; 2011 Apr; 56(4):658-60. PubMed ID: 21298755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvovirus B19-associated hemophagocytic lymphohistiocytosis in a child with precursor B-cell acute lymphoblastic leukemia under maintenance chemotherapy.
    Matsubara K; Uchida Y; Wada T; Iwata A; Yura K; Kamimura K; Nigami H; Fukaya T
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):565-9. PubMed ID: 21617562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.
    Papayannidis C; Derenzini E; Iacobucci I; Curti A; Paolini S; Cilloni D; Baccarani M; Martinelli G
    Am J Hematol; 2009 Dec; 84(12):849-50. PubMed ID: 19844989
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis.
    Göpel W; Schnetzke U; Hochhaus A; Scholl S
    Ann Hematol; 2016 Oct; 95(11):1899-901. PubMed ID: 27488287
    [No Abstract]   [Full Text] [Related]  

  • 6. Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
    Messinger YH; Gaynon PS; Sposto R; van der Giessen J; Eckroth E; Malvar J; Bostrom BC;
    Blood; 2012 Jul; 120(2):285-90. PubMed ID: 22653976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophagocytic lymphohistiocytosis during maintenance treatment of precursor B-cell acute lymphoblastic leukemia.
    Furutani A; Imamura T; Ueda I; Takanashi M; Hirashima Y; Nakatani T; Inaba T; Morimoto A
    Int J Hematol; 2008 Dec; 88(5):610-612. PubMed ID: 19043809
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
    Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
    Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
    Turner SR; Pinsk M
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):58-60. PubMed ID: 18176182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
    Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.
    Delavigne K; Bérard E; Bertoli S; Corre J; Duchayne E; Demur C; Mansat-De Mas V; Borel C; Picard M; Alvarez M; Sarry A; Huguet F; Récher C
    Haematologica; 2014 Mar; 99(3):474-80. PubMed ID: 24142998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis.
    Sathiyamoorthy S; Shad A; Ozdemirli M
    Pediatr Blood Cancer; 2011 May; 56(5):850-2. PubMed ID: 21370422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.
    Hijiya N; Gajjar A; Zhang Z; Sandlund JT; Ribeiro RC; Rubnitz JE; Jeha S; Liu W; Cheng C; Raimondi SC; Behm FG; Rivera GK; Relling MV; Pui CH
    Leukemia; 2004 Oct; 18(10):1581-6. PubMed ID: 15356657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia.
    Andreasson P; Johansson B; Arheden K; Tedgård U; Ljung R; Heim S; Mitelmann F
    Leukemia; 1996 Feb; 10(2):378-83. PubMed ID: 8637252
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia in a child with nephrotic syndrome.
    Bhatia M; Kher K; Minniti CP
    Pediatr Nephrol; 2004 Nov; 19(11):1290-3. PubMed ID: 15372224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations.
    Li F; Zhang X; Wang Y; Yang A; Zhang Z; Tang W; Zhong N; Shi H
    BMC Cancer; 2018 May; 18(1):604. PubMed ID: 29843647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
    Thomson B; Park JR; Felgenhauer J; Meshinchi S; Holcenberg J; Geyer JR; Avramis V; Douglas JG; Loken MR; Hawkins DS
    Pediatr Blood Cancer; 2004 Oct; 43(5):571-9. PubMed ID: 15382275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Rash, Eosinophilia, Systemic Symptoms (DRESS) in a Child With Acute Lymphoblastic Leukemia.
    Thakkar D; Singh Y; Yadav SP
    J Pediatr Hematol Oncol; 2018 May; 40(4):e266-e267. PubMed ID: 29189510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.